Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD44 is a transmembrane glycoprotein that functions as a cell surface adhesion receptor with diverse roles in cellular processes. It is involved in cell-cell and cell-matrix interactions, immune system functions, and neurological functions. Its principal ligand is hyaluronic acid (HA), but it can also interact with osteopontin, collagens, matrix metalloproteinases (MMPs), and fibrin. CD44 is highly expressed in many cancers and regulates metastasis, making it a potential therapeutic target.
CD44 represents a potential therapeutic target in cancer treatment via regulation of metastasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD44 molecule (CD44).